The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
Frequently asked questions
What is the iShares Genomics Immunology and Healthcare ETF (IDNA) expense ratio?
The iShares Genomics Immunology and Healthcare ETF funds expense ratio is 0.47%.
What is iShares Genomics Immunology and Healthcare ETF (IDNA) current stock price?
As of the latest data, iShares Genomics Immunology and Healthcare ETF stock price is $40.95, with a previous close of $40.91. iShares Genomics Immunology and Healthcare ETF gained $0.04 in the last trading session, representing a 0.1% increase.
Does iShares Genomics Immunology and Healthcare ETF (IDNA) pay dividends?
Yes. iShares Genomics Immunology and Healthcare ETF pays semiannual dividends with an annualized yield of 0.68% and an estimated annual payout of $0.28 per share.
